“In other words, DCs are the ‘best supporting actors’ of anti-tumor immunity.”
I guess that makes the T cell Marlon Brando!?!
“I'm gonna make this tumor cell an offer he can't refuse.“
📢 Research Alert! 🧬🔬 🩺 We are super excited that our latest study, led by the great @RubenBill5 & Asa Wirapati, is out: science.org/doi/full/10.1126…
We set out to shed some light on the tumor microenvironment and its impact on cancer progression.
🧵
8/ 🙌 Of course, it takes a village to conduct a study like this, so a hearty thank you, and bravo, to all the clinicians, nurses, researchers, bioinformaticians, technicians and many more, who made this study possible.
9/ 😀📚 If you're hungry for more insights into how patient variation may help us unravel the complexities of cancer, don't miss the full publication here: science.org/doi/full/10.1126…
📣 📣 Do you leave close to Geneva and want to participate in an out-of-the box Virtual Reality-based neuroimmunology project? Contact us! We count on you 😊! @snsf_ch Sinergia, @LabMyspace@miupasteur
We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇
cell.com/immunity/fulltext/S…
A short 🧵:
👉 We also want to advertize a related paper by the team of @merghout and @wolchokj, published in the same issue, which reveals additional insights about the role of neutrophils in mediating effective cancer immunotherapy.
👉 doi.org/10.1016/j.cell.2023.…